MYLAN PHARMS INC FDA Approval ANDA 087672

ANDA 087672

MYLAN PHARMS INC

FDA Drug Application

Application #087672

Application Sponsors

ANDA 087672MYLAN PHARMS INC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL5MG0METHYCLOTHIAZIDEMETHYCLOTHIAZIDE

FDA Submissions

ORIG1AP1982-08-17
LABELING; LabelingSUPPL3AP1989-12-26
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1990-01-31
LABELING; LabelingSUPPL5AP1991-07-01
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-10-15
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1998-02-05
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1998-02-25

Submissions Property Types

SUPPL4Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87672
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHYCLOTHIAZIDE","activeIngredients":"METHYCLOTHIAZIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"METHYCLOTHIAZIDE","submission":"METHYCLOTHIAZIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.